Epidemiology 1
Monday, October 9, 2017
•
FC 06
•
9:30 AM
>
11:00 AM
•
Epidemiology 1
•
G 104
•
FC 06-01
•
Antiretroviral therapy, high-risk human papillomavirus and cervical intraepithelial neoplasia: a systematic review and meta-analysis
See abstract
>
S.
S.
DE SANJOSÉ
•
FC 06-02
•
Incidence trends in HPV-related cancers in Norway, and cases preventable by HPV vaccination
See abstract
>
B.
B.T.
HANSEN
•
FC 06-03
•
A comprehensive landscape of 27 HPV viruses' prevalence and multi-infection patterns, high consistency between the HPV16/18 co-infection preference pattern and the cross-protective efficacy of HPV16/18 vaccine against non-vaccine HPV types.
See abstract
>
B.
B.
SHE
•
FC 06-04
•
Estimation of the overall burden of cancers, precancerous lesions, and genital warts attributable to 9-valent HPV vaccine types in women and men in Europe
See abstract
>
S.
S.
HARTWIG
•
FC 06-05
•
Declines in genital warts diagnoses since change in 2012 to use the quadrivalent HPV vaccine in England: data to end 2016
See abstract
>
M.
M.
CHECCHI
•
FC 06-06
•
Characterization of genotype-specific HPV prevalence in cutaneous warts biopsies
See abstract
>
J.
J.
JONCKHEERE
•
FC 06-07
•
Burden of genital warts in Peru, Argentina and Ecuador: an observational study
See abstract
>
M.
M.
CASHAT
•
FC 06-08
•
An overview of cervical cancer epidemiology and prevention in Scandinavia
See abstract
>
K.
K.
PEDERSEN
•
FC 06-09
•
Type-specific human papillomavirus profile, absolute risk and attributable fraction to cervical cancer and precancerous lesions –a population-based study of 3,083 women in Inner Mongolia, China.
See abstract
>
L.
L.
LI
•
FC 06-10
•
Sex differences in prevalence, incidence and clearance of anogenital human papillomavirus infection in China: a population-based prospective study
See abstract
>
F.
F.
WEI
|